1.	A Pharmacokinetic Study of Actinomycin-D and Vincristine in Children With Cancer Phase: Phase IV Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and under Sponsor: NICHD Protocol IDs: PPRU 10762, NCT00491946
2.	Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms Tumor Phase: Phase III Type: Treatment Status: Active Age: Under 30 at diagnosis Sponsor: NCI, Other Protocol IDs: CDR0000487540, COG-AREN0532, AREN0532, NCT00352534
3.	Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms Tumor Phase: Phase III Type: Treatment Status: Active Age: Under 30 Sponsor: NCI, Other Protocol IDs: CDR0000496508, COG-AREN0533, AREN0533, NCT00379340
4.	Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor Phase: Phase III Type: Supportive care, Treatment Status: Active Age: Under 30 at initial diagnosis Sponsor: NCI, Other Protocol IDs: CDR0000649716, COG-AREN0534, AREN0534, NCT00945009
5.	To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 2 to 20 Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: 100220, IND 59,056, NCT01222780
6.	Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: Under 30 Sponsor: NCI, Other Protocol IDs: CDR0000472893, COG-AREN0321, AREN0321, NCT00335556
7.	Pilot Study of Hyperthermic Peritoneal Perfusion (HIPEC) for Adolescent and Young Adults With Desmoplastic Small Round Cell Tumor Phase: Phase II Type: Treatment Status: Active Age: 3 to 55 Sponsor: Other Protocol IDs: 2009-0528, NCT01277744
8.	Intraperitoneal Radioimmunotherapy With 131I-8H9 for Patients With Desmoplastic Small Round Cell Tumors and Other Solid Tumors Involving the Peritoneum Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 1 and over Sponsor: Other Protocol IDs: 09-090, NCT01099644
9.	Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid Tumors Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 2 to 21 Sponsor: Other Protocol IDs: SorIrin1576, NCT01518413
10.	A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas Phase: Phase I Type: Treatment Status: Active Age: 2 to 21 Sponsor: Other Protocol IDs: RADIANT, NCT01625351
11.	Auto Transplant for High Risk or Relapsed Solid Tumor Phase: No phase specified Type: Treatment Status: Active Age: 70 and under Sponsor: Other Protocol IDs: 2011OC057, MT2011-09C, NCT01505569